UNSPSC 51102820: Bacitracin/neomycin/polymyxin

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class DE109. This VA Drug Class (DE109) classifies this compound as belonging to the group ANTI-INFECTIVE, TOPICAL, OTHER.

UNSPSC 51102820 Bacitracin/neomycin/polymyxin is a Commodity code, but the recent state and local opportunities tagged under it show no direct alignment with topical antibiotic ointments; instead, they reflect a broad mismatch between the code's nominal scope and actual procurement activity. The opportunities solicited include naloxone and drug deactivation systems (Seminole County, Florida), therapeutic pharmacy initiatives and direct-to-manufacturer prescriptions (Texas Health and Human Services Commission), medical and first aid supplies for fire rescue operations (City of Tampa), and generic multi-source pharmaceuticals and over-the-counter products through cooperative purchasing (Minnesota Multistate Cooperative Purchasing Alliance serving state and local facilities across multiple states including Oregon). The issuing bodies span county health departments, state health agencies, municipal fire departments, and state-administered cooperative purchasing consortia, reflecting a fragmented buyer base across health care, emergency services, and pharmacy benefit administration rather than a cohesive procurement focus aligned with topical antibiotics.

The geographic footprint of recent activity spans Florida, Texas, Minnesota, and Oregon, with additional multi-state participation through cooperative purchasing mechanisms. Representative solicitations include the City of Tampa's IFB for medical and first aid supplies due March 13, 2026 (estimated contract value $700,000 with Small Local Business Enterprise set-aside and discount), the Minnesota Multistate Cooperative Purchasing Alliance RFP for generic pharmaceuticals and OTC products due March 26, 2026 with July 1, 2026 effective date, and the Texas Health and Human Services Commission RFI on direct-to-manufacturer prescriptions posted April 3, 2026. Seminole County's IFB for naloxone and drug deactivation systems (due July 26, 2023 per the solicitation date) reflects annual procurement of prescription and medical support products. The code shows minimal activity directly relevant to bacitracin/neomycin/polymyxin topical antibiotics; procurement under this UNSPSC designation appears to serve as a catch-all for broader pharmaceutical and medical supply categories rather than the specific commodity the code name describes.